Posted by Michael Wonder on 02 May 2017
Survey shows biotech industry buoyant, but fearing imminent policy change
2 May 2017 - AusBiotech’s annual survey of biotechnology industry CEOs shows the strongest year on record, but the result is overshadowed by pervasive fear that proposed changes to the R&D Tax Incentive will damage Australia’s flourishing and globally-competitive sector.
AusBiotech released the Biotechnology Industry Position Survey 2017 showing industry leaders’ concern that commercialisation of Australian biomedical research is set to be damaged if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the R&D Tax Incentive is adopted by the Federal Government in the up-coming Budget.
